Price target
399.450.000.00%
The 24 analysts offering 1 year price forecasts for DUL have a max estimate of — and a min estimate of —.
Analyst rating
Based on 31 analysts giving stock ratings to DUL in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
DUL EPS for the last quarter is −0.43 EUR despite the estimation of −0.46 EUR. In the next quarter EPS is expected to reach 0.32 EUR. Track more of Alnylam Pharmaceuticals, Inc financials and stay on top of what is up with the company.
In the next quarter Alnylam Pharmaceuticals, Inc revenue is expected to reach 786.75 M EUR. Check out Alnylam Pharmaceuticals, Inc revenue and earnings and make informed decisions.
According to analysts, DUL price target is 399.45 EUR with a max estimate of 485.60 EUR and a min estimate of 276.88 EUR. Check if this forecast comes true in a year, meanwhile watch Alnylam Pharmaceuticals, Inc stock price chart and keep track of the current situation with DUL news and stock market news.
We've gathered opinions of 31 analysts rating DUL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.